CI · News · 20260805N
PBM Regulatory Scrutiny
Cigna Group · 2026-08-05 · Importance 23 · Surprise 24
Cigna’s pharmacy benefit management operations, including Evernorth and Express Scripts, face heightened regulatory uncertainty in the United States. Third-party analysis identifies potential PBM regulation changes as a material risk to the company’s future business portfolio and valuation. The reporting does not specify a proposed federal law, effective date, or quantified financial impact.
Key facts
- Cigna Group's stock dropped 9.0% despite strong Q2 2026 results. source